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Abstract
Background and Purpose—Increased blood-brain barrier (BBB) permeability occurs in
cerebral small vessel disease (SVD). It is not known if BBB changes predate progression of SVD.
Methods—We followed up patients with non-disabling lacunar or cortical stroke and BBB
permeability MR imaging following their original stroke. About three years later, we assessed
functional outcome (Oxford Handicap Score, OHS, poor outcome defined as 3-6), recurrent
neurological events and white matter hyperintensity (WMH) progression on MRI.
Results—Amongst 70 patients, mean age 68 (SD±11) years, median time to clinical follow up
was 39 months (IQR 30-45), median OHS was 2 (IQR 1-3); poor functional outcome was
associated with higher baseline WMH score (p<0.001) and increased basal ganglia BBB
permeability (p=0.046). Amongst 48 patients with follow-up MRI, WMH progression at follow-up
was associated with baseline WMH (ANCOVA p<0.0001) and age (ANCOVA p=0.032).
Conclusions—Further long term studies to evaluate the role of BBB dysfunction in progression
of SVD are required in studies that are large enough to account for key prognostic influences such
as baseline WMH and age.
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Introduction
The BBB becomes increasingly permeable with normal advancing age,1 particularly in
patients with vascular dementia1 and small vessel disease (SVD, Figure 1).2-4 Cross-
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sectional studies do not determine whether increased BBB permeability predates progression
of SVD and therefore might be causative. We followed up patients previously recruited in
our cross-sectional study of BBB permeability changes in lacunar stroke2 to see if increased
BBB permeability might predate progression of SVD.
Methods
We originally recruited 97 previously independent patients with non-disabling ischaemic
stroke,2 half lacunar, half cortical (controls). We assessed stroke severity (NIHSS score),
performed diagnostic MR imaging (with DWI, T1, T2, FLAIR, T2*) to confirm stroke
subtype and quantify white matter hyperintensities (WMH). We assessed BBB permeability
in basal ganglia, cortex, white matter and lateral ventricular cerebrospinal fluid (CSF) 1-3
months after the index stroke with sequential MR T1 imaging before and after intravenous
gadolinium (described previously2, 5). The study was approved by the Lothian Research
Ethics Committee (2002/W/RA/03); all participants gave written informed consent.
About three years later, we followed-up all patients to determine functional status (Oxford
Handicap Score, OHS,6 similar to the modified Rankin Score: poor functional
outcome=OHS 3-6, dead=OHS 6), recurrent strokes and assess SVD progression on
structural MR imaging. We cross-checked the patients’ histories with hospital records.
Follow-up MR imaging was performed on the same 1.5T MR scanner (GE Signa LX,
Milwaukee, WI, USA, 22 mTm−1 maximum strength gradients) using the same diagnostic
sequences (T1, T2, FLAIR, T2*, DWI) described previously.2 We analysed imaging
features blind, noting new infarcts or haemorrhages, WMH (Fazekas score7) and change in
WMH (Prins score8). The intra-class correlation coefficient for WMH rating by the
neuroradiologist was 0.964. We registered follow-up to baseline scans and measured
intracranial, whole brain, and WMH volumes using a validated multispectral image analysis
tool.9 We masked infarcts to avoid confounding WMH volume,10 normalised brain and
WMH volumes to intracranial volume (ICV) and determined WMH volume change.
We performed univariate and multivariate analysis (binary logistic regression) to identify
variables associated with functional status and WMH change at follow-up adjusted for
duration of follow-up. We performed uni- and multi-variate linear regression to examine
associations between BBB permeability at baseline, WMH progression and functional
outcome. We analysed factors associated with WMH volume change by ANCOVA. All
analyses were performed in Minitab version 15, State College, Pennsylvania, US or SAS 9.1
(www.sas.com).
Results
We obtained clinical follow-up on 70/97 (78%) and MR imaging on 48 (49% of 97) of the
original study patients. The 70 patients with clinical follow-up did not differ from the 27
without clinical follow-up in baseline age (mean at original presentation 68+/−11 vs 63+/
−12, p=NS), median NIHSS (both 2 IQR 1-3), hypertension (both 66%) or lacunar stroke
(50% vs 43%). The median baseline Fazekas deep and periventricular WMH scores were
each 1; periventricular and deep Fazekas scores were >2 in 20 and nine patients respectively.
At clinical follow-up at median 39 months (IQR 30-48), 25% had poor outcome (12 OHS
3-5, six dead). Twenty-five had clinical and/or imaging evidence of recurrent neurological
events (36%): two, clinically-diagnosed recurrent stroke; 23, new focal weakness; four, new
infarct on follow-up imaging. In univariate analyses, poor functional outcome was
associated with increasing age, higher baseline WMH score and basal ganglia BBB
permeability, but not baseline NIHSS, hypertension, diabetes or stroke subtype (Table 1).
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On multivariate logistic regression (adjusted for baseline age, WMH score, BBB
permeability) predictors of poor outcome were baseline total WMH score (OR 4.8, 2.0-11.4,
p<0.001) and basal ganglia BBB permeability (OR 2.2, 1.0-4.6, p=0.046).
Forty-eight patients had follow-up MR imaging, median 39 (IQR 30-45) months after index
stroke; baseline age (67+/−10), median NIHSS (2, IQR 2-3), proportion hypertensive (65%),
lacunar index stroke (48%) and WMH score were the same as for all 70 with clinical follow-
up. 6/48 (13%) were OHS=3-5.
WMH score had increased in 33/48 and remained unchanged in 15/48 (according to Prins
and Fazekas scores, Figure 1b). On univariate analyses, baseline WMH score, but not age or
time since stroke, strongly predicted progression of WMH (OR 8.7, 2.1-35.3, p<0.001).
Median WMH volume at baseline was 8.5 ml (IQR 5.9-15.2), at follow-up was 12.2 ml
(IQR 8.6-19.7), median increase 3.2 ml (IQR 1.2-7.5, p<0.0001). The strongest predictors of
increasing WMH volume at follow-up were baseline WMH volume (ANCOVA p<0.0001)
and age (ANCOVA p=0.032). WMH volume at follow-up increased by: 1.80 times
(1.56-2.08) per unit (mm3) of WMH volume and 1.01 times (1.00-1.02) per additional year
of age at baseline.
Discussion
Poor functional outcome three years after lacunar or mild cortical ischaemic stroke was
associated with having more WMH, being older and having increased BBB permeability in
the basal ganglia. Worsening of WMH was dominated by having more WMH at baseline
and older age. A third had clinical/imaging evidence of recurrent neurological events,
although only two were formally diagnosed as recurrent stroke, consistent with recent
recognition of WMH-associated subtle neurological symptoms.11 Long term poor functional
outcome and WMH progression were not associated with vascular risk factors, baseline
NIHSS or stroke subtype, possibly because the study was small, NIHSS very mild, or due to
secondary prevention, although this does not control risk factors perfectly.
WMH increased in most patients at follow-up. Similar change in WMH scores (27-74%
increase)12 or volume (1.1-2.4 ml) have been noted previously but the magnitude of effect of
WMH or age on WMH progression, and the association with BBB permeability, are novel.1
These data on WMH progression, particularly the 95% confidence intervals (increase over
three years of 1.56-2.08 times per additional mm3 of baseline WMH volume and 1.00-1.02
times per additional year of age at baseline), provide useful data for sample size calculations
for studies wishing to use WMH change as a surrogate outcome measure.
The study strengths include testing clinical and imaging predictors of SVD progression, use
of qualitative and quantitative WMH measures, careful blinding, validated imaging
methods.5,9,10 Weaknesses include small sample size, limited power for multivariate testing,
22% loss to clinical follow-up (possibly reflecting the three-year time lapse).
Future studies assessing BBB permeability in SVD should: assess recurrent stroke, covert
neurological symptoms, accumulating SVD features, vascular risk factors; track BBB
permeability to new lesion formation;4 be powered to adjust for multiple overlapping
covariates, particularly WMH load.
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Figure 1.
72-year-old patient with right hemisphere lacunar stroke. (a) two days after stroke MR DWI
shows the acute right centrum semiovale lacunar infarct, T2* shows a few microbleeds,
FLAIR shows numerous WMHs. BBB imaging six weeks later: FLAIR 30 minutes after iv
Gadolinium (Gd) shows Gadolinium in cortical sulci and perivascular spaces (arrows). (b)
FLAIR and T2* images two years later show increased WMHs and microbleeds (baseline
FLAIR and T2* shown for comparison).
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Table 1
Predictors of poor outcome (OHS 3-6) three years after lacunar or mild cortical stroke
Univariate Multivariate
Variable OR/unit
increase
95% CI P value OR (95% CI)/
unit increase
P value
Age (per year) 1.09 1.03-1.17 0.007
Male 1.50 0.4-6.2 0.5
Hypertension y/n 1.00 0.3-3.1 1.0
Diabetes y/n 1.50 0.3-6.7 0.6
Cortical v lacunar
stroke
1.67 0.55-5.05 0.364
Baseline NIHSS 1.10 0.7-1.9 0.6
Cortical grey
permeability
1.30 0.6-2.7 0.5 1.37 (0.61–3.10)* 0.4
Basal ganglia
permeability
2.10 1.1-4.3 0.027 2.15 (1.01-4.57)* 0.046
White matter
permeability
0.9 0.2-5.5 0.9 1.5 (0.19–11.8)* 0.7
CSF permeability 0.8 0.6-1.0 0.06 0.8 (0.6–1.1) * 0.2
Fazekas DWMH score
(0-3)
3.91 1.82-8.39 <0.001 3.3 (1.4-7.5)# 0.005
Fazekas PVWMH
score (0-3)
4.09 1.90-8.78 <0.001 3.5 (1.4-8.6)# 0.006
Fazekas WMH
combined score (0-6)
4.50 2.0-10.0 <0.001 4.8 (2.0-11.4)* +
4.1 (1.6-10.3)# +
<0.001
*
=corrected for baseline WMH;
#
=corrected for age;
+per unit increase in WMH
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